MLchartDataset catalogue

confirmatory clinical trial

Term · Oncology and biomedicine · MLC-T-ONC-001992

A study that confirms how well a new treatment works after it was shown in early-phase clinical trials that it might be beneficial for patients. New drugs that are given an accelerated approval by the U.S. Food and Drug Administration (FDA) to treat a serious or life-threatening disease, such as cancer, are required to be tested in a confirmatory clinical trial. This is done to verify that they really work when they are tested on many more people in a randomized study. The FDA may remove a drug from the market if a confirmatory clinical trial shows that the drug is not beneficial for patients.

Table 1. Record
IdentifierMLC-T-ONC-001992
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001992",
  "term": "confirmatory clinical trial",
  "field": "Oncology and biomedicine",
  "definition": "A study that confirms how well a new treatment works after it was shown in early-phase clinical trials that it might be beneficial for patients. New drugs that are given an accelerated approval by the U.S. Food and Drug Administration (FDA) to treat a serious or life-threatening disease, such as cancer, are required to be tested in a confirmatory clinical trial. This is done to verify that they really work when they are tested on many more people in a randomized study. The FDA may remove a drug from the market if a confirmatory clinical trial shows that the drug is not beneficial for patients.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/confirmatory-clinical-trial/"
}

Record 5,205 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.